Dendreon Announces Election of Dennis M. Fenton to Board of Directors

Dendreon Corporation

today announced that Dennis M. Fenton has been elected to the Company's Board of Directors, effective November 8, 2011. Dr. Fenton has 30 years of pharmaceutical and biotechnology experience, including over two decades at Amgen, Inc., where he played an instrumental role in the development of the company into a global, fully integrated, multi-billion dollar organization. Dr. Fenton's broad background includes executive leadership roles in manufacturing, process development, sales and marketing, and operations and quality control.